SYRA US EQUITY Health Care Health Care CIK: 1922335

Syra Health Corp (SYRA) Quant Factor Diagnostic & Fair Value Model

Syra Health Corp (Ticker: SYRA) is listed in the Health Care sector (Health Care). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.

$0.89
+751.92% Latest Close (2026-10-23)
Market Cap: $11.79M
P/E Ratio: 83.0
Momentum Strength 3M / 12M
+102.28%
1M: +189.54% 12M: 0.00%
Quality (ROE) Point-in-Time
-
Trailing Return on Equity
Technical Trend RSI 14
81.8
SMA50: $0.38 SMA200: $0.41
Valuation Multiplier Trailing
83.0
Premium Multiple (> 30x P/E)
📊 Valuation & Multi-Factor Diagnostic
Premium Multiple (> 30x P/E)

SYRA trades at 83.0x P/E, reflecting market-implied growth expectations for forward revenue and cash flow.

⚡ Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.

📈 Daily Candlestick & Volume Quant Chart

Interactive lightweight price action & volume breakdown over recent 90 trading days.

均线整理 (MA20/50) Piotroski F-Score: 2/9 (Under Pressure or Early Stage Growth)

Official Point-in-Time Financial Filing History

Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.

备案 CIK: 1922335 · 10-K 年报 / 10-Q 季报
Form Period End Filing Timestamp (Point-in-Time) Revenue Net Income Operating CF EPS (Diluted)
No point-in-time filings synced yet. Automated batch scheduler will align CIK: 1922335

💡 Methodology & Frequently Asked Questions

Key reference details regarding Syra Health Corp (SYRA) valuation multiples, momentum factors, and point-in-time filing conventions.

How should SYRA's current valuation multiple be interpreted? ↓
SYRA trades at a trailing P/E of 83.0x within the Health Care sector (premium multiple (> 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are SYRA's key momentum and technical factor indicators? ↓
As of the latest close, SYRA shows a 1-month return of +189.54%, 3-month return of +102.28%, and 12-month return of 0.00%, with a 14-day RSI of 81.8. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for SYRA? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can SYRA be incorporated into systematic factor models? ↓
SYRA can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.

Related Peers & Valuation Comparison in Health Care

Dense Internal Network Mesh